Literature DB >> 2729945

Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.

T Hayashi1, Y Watanabe, K Kumano, R Kitayama, T Muratani, T Yasuda, I Saikawa, J Katahira, T Kumada, K Shimizu.   

Abstract

The protective effect of piperacillin against the nephrotoxicity of cisplatin was compared with that of fosfomycin in Fischer 344 rats. Blood urea nitrogen, serum creatinine, and morphological changes were evaluated as the renal toxicological parameters. Rats receiving 2 mg of cisplatin per kg of body weight for 5 days showed significant (P less than 0.01 by multiple-comparison test) elevation of blood urea nitrogen and serum creatinine concentrations compared with rats receiving saline alone and also exhibited development of cell lesions in the pars recta of the tubules in the outer stripe of the outer medulla. However, piperacillin (250 and 1,000 mg/kg) significantly (P less than 0.01 by multiple-comparison test) reduced these toxicological parameters in comparison with results for cisplatin alone. The protective effect of piperacillin was superior to that of fosfomycin, although platinum levels in the kidney were higher with the combination of cisplatin and piperacillin than with cisplatin plus fosfomycin. Although the nephrotoxicity of cisplatin was also reduced when cisplatin was administered concomitantly with sodium chloride in mole-equivalents to 250 and 1,000 mg of piperacillin per kg, its protective effect was less than that of the corresponding piperacillin dose. These results suggest that piperacillin may have a role as a protective agent against the nephrotoxicity of cisplatin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729945      PMCID: PMC172470          DOI: 10.1128/AAC.33.4.513

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Stimulation of the renal endoplasmic reticulum calcium pump: a possible biomarker for platinate toxicity.

Authors:  L M De Witt; T W Jones; L Moore
Journal:  Toxicol Appl Pharmacol       Date:  1988-02       Impact factor: 4.219

2.  Effect of cisplatin on organic ion transport in membrane vesicles from rat kidney cortex.

Authors:  P D Williams; G H Hottendorf
Journal:  Cancer Treat Rep       Date:  1985 Jul-Aug

3.  Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration.

Authors:  C L Litterst
Journal:  Toxicol Appl Pharmacol       Date:  1981-10       Impact factor: 4.219

4.  A study of the protective effect of chloride salts on cisplatin nephrotoxicity.

Authors:  P T Daley-Yates; D C McBrien
Journal:  Biochem Pharmacol       Date:  1985-07-01       Impact factor: 5.858

5.  Renal toxicity studies of protein-bound platinum(cis).

Authors:  W C Cole; W Wolf
Journal:  Chem Biol Interact       Date:  1981-06       Impact factor: 5.192

6.  Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin, and piperacillin and cefoperazone in rabbits.

Authors:  T Hayashi; Y Watanabe; K Kumano; R Kitayama; T Yasuda; I Saikawa; K Totsuka; T Kumada; K Shimizu
Journal:  J Antibiot (Tokyo)       Date:  1986-05       Impact factor: 2.649

7.  The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.

Authors:  P T Daley-Yates; D C McBrien
Journal:  Biochem Pharmacol       Date:  1982-07-01       Impact factor: 5.858

8.  [Reduction of cisplatin toxicity by fosfomycin in animal models].

Authors:  I Ohtani; K Ohtsuki; T Aikawa; Y Sato; T Anzai; J Ouchi; T Saito
Journal:  Gan To Kagaku Ryoho       Date:  1984-11

9.  [Preventive effect of fosfomycin on the renal toxicity of cisplatin].

Authors:  M Kurebe; T Niizato; M Sanda; H Sasaki; H Hayasaka
Journal:  Jpn J Antibiot       Date:  1985-01

10.  Modification of cisplatin toxicity by antioxidants.

Authors:  K Sugihara; M Gemba
Journal:  Jpn J Pharmacol       Date:  1986-02
View more
  2 in total

1.  Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.

Authors:  D J Stewart; C Dulberg; J M Molepo; N Z Mikhael; V A Montpetit; M D Redmond; R Goel
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Fatemeh Eshraghi-Jazi; Farzaneh Ashrafi; Hamid Nasri; Ardeshir Talebi; Tahereh Safari; Maryam Haghighi; Azam Mansouri
Journal:  Int J Nephrol       Date:  2012-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.